Neurotrophins (NTs) are growth factors, which were initially discovered in the nervous system and play a pivotal role in the development, maintenance and regeneration of nerve fibres. The NTs include nerve growth factor (NGF), brainderived neurotrophic factor (BDNF), NT-3 and NT-4/-5. NT precursors, pro-NGF/BDNF are high-affinity ligands for the pan-neurotrophin receptor p75 (p75  NTR ) which together with sortilin promotes apoptosis through the regulation of the rate of p75 cleavage by sortilin, a prerequisite for pro-neurotrophin initiated cell death. [9] [10] [11] [12] Although functions of these receptor isoforms are still not clearly understood, accumulating evidence suggests a contribution to cell growth and migration. 13 NTs have also been demonstrated to act as signal transduction molecules between immune cells, structural cells and neuronal cells in allergic diseases. [14] [15] [16] Neurotrophin-expressing nerves are in direct anatomic contact to MCs and MCdriven skin inflammation has been shown to be impaired in the absence of sensory nerves. 17 NTs have been demonstrated to promote chemotaxis, maturation and survival of MCs which on the other hand produce several NTs. 9, 14, 15, [18] [19] [20] [21] [22] [23] [24] [25] [26] The bidirectional interaction of NTs and MCs suggest a contribution of NTs to a disease such as mastocytosis. However, the role of NTs in mastocytosis has not been investigated sufficiently so far. Table 1 . A part of the study population has already been described previously. 28 The protocol was approved by the local ethics committee and this study was conducted in accordance with the Declaration of Helsinki.
Tissue processing and identification of KIT mutations (e-methods 1)
Reagents and analysis of serum parameters (e-methods 2)
Isolation and culture of human SMCs from skin biopsies
Human SMCs were purified from fresh skin samples and cultured as described 
Flow cytometry
Flow cytometry was performed as described previously. CT methods. 32 All analyses were conducted in duplicates.
Detection of transcript variants of Trk receptors with PCR
To analyze the expression of transcript variants of TrkA, B and C on cultured SMCs from patients with mastocytosis and controls, primers were synthesized (Microsynth, Balgach, Switzerland) (Supplementary Table 1 ) and PCRs performed as described previously. 9, 12, 33 The amount of human template cDNA in different PCRs was determined with a parallel PCR for a 114bp fragment of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene with following primers, GAPDH_forward:
CCA CAT CGC TCA GAC ACC AT and GAPDH_reverse: GGC AAC AAT ATC CAC TTT ACC AGA GT. 11 In each PCR, human brain cDNA and distilled water were used as positive and negative control, respectively.
Immunohistochemistry staining
Immunohistochemistry was performed as described previously 34 using serial paraffin embedded sections (4µm) with the help of mAbs to TrKA, B and C from R&D Systems and toluidine blue. Appropriate isotype-matched controls were included.
TrkA, B, C and toluidine blue positive cells were counted in 600 consecutive fields per section (300 upper dermis, 300 lower dermis; magnification x200, field diameter 0.05 mm², total area 30 mm²) under microscope (BH-2 microscope and DF70 camera, Olympus Europe GmbH, Hamburg Germany) and the mean of Trk + or toluidine blue + cells/mm² was calculated.
Immunofluorescence staining
Immunofluorescence staining was performed on 4-µm skin and gut sections of paraformaldehyde-fixed and paraffin-embedded tissue as described elsewhere. ELISAs (e-methods 4)
Migration assays
Cell migration was performed in 24-well Transwell cell culture chambers (Costar, Corning, NY) in accordance with published protocols 36 with some minor variations (emethods 5).
Statistical analysis
Differences between the groups were assessed using the Chi² test for qualitative 
RESULTS

Increased serum levels of NGF-β, NT-3 and -4 in patients with mastocytosis
We observed significantly increased serum levels of NGF-β (P=.04), NT-3 (P=.04), NT-4 (P=.002) in patients with mastocytosis compared to controls (Figure 1 ). NGF-β levels were highest in patients with IBMM, but did only reach statistical significance in patients with ISM with skin involvement (P=.004) and all patients with ISM (P=.001).
Conversely, patients with a pure CM had the highest levels of BDNF, NT-3 (P= .027) and similar to MIS of NT-4 (P= .045), but also patients with ISM showed significantly higher levels of NT-4 (P=.02) compared to controls. In the analysis of the separate subgroups of ISM, only in patients with ISM and skin involvement, a narrow significance was reached (P=.048), but not in patients with SSM or IBMM. There were no significant differences between BDNF levels of patients with mastocytosis compared to controls or between NT levels of the different mastocytosis variants. blood levels in patients with mastocytosis. We did not observe significant differences in NT levels between mastocytosis patients carrying an activating KIT mutation compared to those without, analyzed in a subgroup of n=24 patients (data not shown).
For In human intestinal MCs, NT-3, but not NGF, has been shown to promote proliferation and to reduce apoptosis of human intestinal MCs via TrkC together with SCF. 24 Conversely, increased numbers of MC have been observed in the neonatal skin of NT-3-overexpressing mice, without showing a higher rate of MC proliferation 48 . However, the expression and presumably also functions of NTs and their high affinity receptors for NTs differs between MCs from humans and mice and also between different human tissues and human cell lines. 9, 14, 15, [18] [19] [20] [21] [22] [23] [24] [25] [26] 48 In this study, we could demonstrate for the first time significantly higher circulating 
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